Trial
NCT02782052
Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
—
Condition
Pulmonary Arterial Hypertension
Intervention
Nebulized ipratropium bromide
Why stopped
Sponsor's decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-01-29